Indian drugmakers earn a significant share of revenue from the United States, the largest importer of Indian pharma products.

Donald Trump, while recalling his conversation with Prime Minister Narendra Modi, said he made it clear to him that US will ...

Goldman Sachs said that the “reciprocal tariff” plan is expected to impact India in three ways: a) Country-level reciprocity, b) Product-level reciprocity, and c) Reciprocity including non-tariff ...

The U.S. Department of Government Efficiency (DOGE), overseen by billionaire Elon Musk, has canceled a $21 million fund ...

The new tariff plans of US President Donald Trump will lift near-term inflation and hurt growth in the medium term according to a report by Standard Chartered. Show Full Article The report says ...

Convergence between India and the United States on bilateral, regional and global issues is much greater than divergences on ...

In a joint televised interview with billionaire Elon Musk, US President Donald Trump made it clear that India will not be ...

Indian drugmakers earn a significant share of revenue from the US, the largest importer of Indian pharma products ...

The Nifty Pharma index dropped as much as 2% in early trade. Sun Pharma fell nearly 2%, Dr Reddy’s dropped as much as 4%, and ...

From Delhi's new CM announcement today to Trump's pharma tariff threat and Tesla's India plans — Here are the top 11 news ...

Shares of Indian pharmaceutical companies slid 2% on Wednesday after U.S. President Donald Trump said he intends to impose ...

This was originally published in the India File newsletter, which is issued every Tuesday. Sign up here to get latest news ...